390 related articles for article (PubMed ID: 23496921)
1. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
[TBL] [Abstract][Full Text] [Related]
2. Into the valley of death: research to innovation.
Hudson J; Khazragui HF
Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848
[TBL] [Abstract][Full Text] [Related]
3. Leveraging Industry-Academia Collaborations in Adaptive Biomedical Innovation.
Stewart SR; Barone PW; Bellisario A; Cooney CL; Sharp PA; Sinskey AJ; Natesan S; Springs SL
Clin Pharmacol Ther; 2016 Dec; 100(6):647-653. PubMed ID: 27617845
[TBL] [Abstract][Full Text] [Related]
4. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
Chung TD
Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
[TBL] [Abstract][Full Text] [Related]
5. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
6. Drug discovery: new models for industry-academic partnerships.
Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
[TBL] [Abstract][Full Text] [Related]
7. Strategic R&D transactions in personalized drug development.
Makino T; Lim Y; Kodama K
Drug Discov Today; 2018 Jul; 23(7):1334-1339. PubMed ID: 29574213
[TBL] [Abstract][Full Text] [Related]
8. Joint academic and industrial efforts towards innovative and efficient solutions for clinical needs.
De Pieri A; Ribeiro S; Tsiapalis D; Eglin D; Bohner M; Dubruel P; Procter P; Zeugolis DI; Bayon Y
J Mater Sci Mater Med; 2018 Jul; 29(8):129. PubMed ID: 30066293
[TBL] [Abstract][Full Text] [Related]
9. University - industry collaborations: models, drivers and cultures.
Ehrismann D; Patel D
Swiss Med Wkly; 2015; 145():w14086. PubMed ID: 25658854
[TBL] [Abstract][Full Text] [Related]
10. Racing to define pharmaceutical R&D external innovation models.
Wang L; Plump A; Ringel M
Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
[TBL] [Abstract][Full Text] [Related]
11. Organizing for innovation: towards successful translational research.
West W; Nightingale P
Trends Biotechnol; 2009 Oct; 27(10):558-61. PubMed ID: 19683820
[TBL] [Abstract][Full Text] [Related]
12. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
Iida K; Yano T; Ikemori M; Ishida T; Nishimura N
Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438
[TBL] [Abstract][Full Text] [Related]
13. Powered by Open Innovation: Opportunities and Challenges in the Pharma Sector.
Martinez-Grau MA; Alvim-Gaston M
Pharmaceut Med; 2019 Jun; 33(3):193-198. PubMed ID: 31933287
[TBL] [Abstract][Full Text] [Related]
14. The anatomy of medical research: US and international comparisons.
Moses H; Matheson DH; Cairns-Smith S; George BP; Palisch C; Dorsey ER
JAMA; 2015 Jan; 313(2):174-89. PubMed ID: 25585329
[TBL] [Abstract][Full Text] [Related]
15. Professional translational research: a new hybrid paradigm in early drug discovery.
Nussbaumer P; Klebl B
Future Med Chem; 2015; 7(14):1879-89. PubMed ID: 26420644
[TBL] [Abstract][Full Text] [Related]
16. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare.
Wellenreuther R; Keppler D; Mumberg D; Ziegelbauer K; Lessl M
Drug Discov Today; 2012 Nov; 17(21-22):1242-8. PubMed ID: 22521665
[TBL] [Abstract][Full Text] [Related]
17. Alcohol medications development: advantages and caveats of government/academia collaborating with the pharmaceutical industry.
Litten RZ; Ryan M; Falk D; Fertig J
Alcohol Clin Exp Res; 2014 May; 38(5):1196-9. PubMed ID: 24689461
[TBL] [Abstract][Full Text] [Related]
18. EATRIS, a vision for translational research in Europe.
Becker R; van Dongen GA
J Cardiovasc Transl Res; 2011 Jun; 4(3):231-7. PubMed ID: 21544739
[TBL] [Abstract][Full Text] [Related]
19. ReRouting biomedical innovation: observations from a mapping of the alternative research and development (R&D) landscape.
Greenberg A; Kiddell-Monroe R
Global Health; 2016 Sep; 12(1):54. PubMed ID: 27627882
[TBL] [Abstract][Full Text] [Related]
20. Accessing external innovation in drug discovery and development.
Tufféry P
Expert Opin Drug Discov; 2015 Jun; 10(6):579-89. PubMed ID: 25910932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
